Clovis Oncology Correlations
| CLVSDelisted Stock | USD 0.09 0.02 24.00% |
The current 90-days correlation between Clovis Oncology and Porvair plc is 0.27 (i.e., Modest diversification). The correlation of Clovis Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Clovis Oncology Correlation With Market
Significant diversification
The correlation between Clovis Oncology and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Clovis Oncology and DJI in the same portfolio, assuming nothing else is changed.
Clovis |
Moving together with Clovis Stock
Moving against Clovis Stock
| 0.84 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.72 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.71 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.69 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.63 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.61 | WMT | Walmart Aggressive Push | PairCorr |
| 0.6 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.57 | HPQ | HP Inc | PairCorr |
| 0.56 | XOM | Exxon Mobil Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.51 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.49 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.41 | VFS | VinFast Auto | PairCorr |
| 0.37 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.35 | MSFT | Microsoft Aggressive Push | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Clovis Stock performing well and Clovis Oncology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Clovis Oncology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| DENN | 2.51 | (0.04) | 0.01 | 0.10 | 3.63 | 6.40 | 26.32 | |||
| FWRG | 2.25 | (0.04) | 0.02 | 0.10 | 2.91 | 4.35 | 22.87 | |||
| PNR | 0.86 | 0.24 | 0.25 | 0.45 | 0.48 | 1.95 | 5.19 | |||
| BJRI | 2.02 | 0.04 | 0.04 | 0.14 | 2.26 | 4.59 | 13.19 | |||
| DINO | 1.53 | (0.34) | 0.00 | (0.16) | 0.00 | 2.75 | 11.79 | |||
| PVARF | 0.37 | 0.08 | 0.00 | 0.70 | 0.00 | 0.00 | 10.45 | |||
| PWWRF | 0.46 | (0.20) | 0.00 | 0.69 | 0.00 | 0.00 | 0.00 | |||
| PTLO | 1.87 | (0.21) | 0.00 | (0.12) | 0.00 | 4.15 | 12.73 |
Clovis Oncology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Clovis Oncology stock to make a market-neutral strategy. Peer analysis of Clovis Oncology could also be used in its relative valuation, which is a method of valuing Clovis Oncology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Clovis Oncology Corporate Management
| Anna Sussman | VP Relations | Profile | |
| Patrick MA | CEO, CoFounder | Profile | |
| BSc BSc | Exec Officer | Profile | |
| Thomas BSc | Ex Officer | Profile | |
| Daniel Muehl | Principal Financial Officer, Principal Accounting Officer | Profile |
Still Interested in Clovis Oncology?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.